Anika Therapeutics (ANIK) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to -$26.0 million.
- Anika Therapeutics' Other Gross PP&E Adjustments rose 1518.09% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.0 million, marking a year-over-year increase of 1518.09%. This contributed to the annual value of $57.1 million for FY2024, which is 1407.91% up from last year.
- According to the latest figures from Q3 2025, Anika Therapeutics' Other Gross PP&E Adjustments is -$26.0 million, which was up 1518.09% from $65.1 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Other Gross PP&E Adjustments ranged from a high of $65.1 million in Q2 2025 and a low of -$34.8 million during Q2 2022
- In the last 5 years, Anika Therapeutics' Other Gross PP&E Adjustments had a median value of -$25.2 million in 2021 and averaged -$1.3 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 5913.45% in 2022, then soared by 30831.41% in 2025.
- Anika Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $62.6 million in 2021, then decreased by 3.22% to $60.6 million in 2022, then fell by 17.42% to $50.1 million in 2023, then rose by 14.08% to $57.1 million in 2024, then tumbled by 145.53% to -$26.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$26.0 million in Q3 2025, compared to $65.1 million in Q2 2025 and $59.5 million in Q1 2025.